Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Ryan Crowe - Vice President, Investor Relations Leonard Schleifer - Board Co-Chair, Co-Founder, President and Chief Executive Officer George Yancopoulos - Board Co-Chair, Co-Founder, President and Chief Scientific Officer Marion McCourt - Executive Vice President and Head of Commercial Robert Landry - Executive Vice President and Chief Financial Officer Conference Call Participants Ev ...